Latest news and events

Latest News from the Partnership

The figure (A-D) illustrates the process from raw electron micrographs showing individual protein molecules (green boxes) to the building of a protein model. Image by Milena Timcenko

2019.08.01 | People , Research news, Publication

Researchers at DANDRITE and collaborative partners have used cutting-edge electron microscopy to reveal the first structures of the P4-ATPase lipid flippase; a crucial protein for cell viability

PhD-student Milena Timcenko and Assistant Professor Joseph A. Lyons give an insight into their recently published article in the renowned journal Nature “Structure and autoregulation of a P4-ATPase lipid flippase”.

Dr. Irep Gözen. Photo by Oda Hveem
PhD student Elif Köksal. Photo by Kristin Ellefsen
Photo: Spontaneously formed protocells, which resemble balloons anchored to a surface by a network of nanotubes. Image is visualized by 3D confocal microscopy by Elif Köksal.

2019.07.24 | Research news, People

NCMM-EMBL Group Leader Irep Gözen works within chemical life sciences, bionanotechnology and membrane systems

Dr. Irep Gözen has a PhD in chemistry from the Chalmers University of Technology, Sweden, and was previously a postdoctoral researcher in Professor Vinothan Manoharan’s group at Harvard University. She joined NCMM as head of the Bionanotechnology and Membrane Systems Group in 2016. She also holds an adjunct associate professor position at the…

2019.07.09 | News from the management, People

Group Leader position at NCMM

NCMM offers a Group Leader position with a start-up package in Precision Medicine

Dr Ellen Bushell. Photo: MIMS

2019.07.02 | People

Introducing MIMS-EMBL Group Leaders: Ellen Bushell - Parasite-host interactions that govern malaria infection and disease

Dr Bushell, who is originally from Umeå, joined MIMS as a group leader from the Wellcome Sanger Institute near Cambridge in Autumn of 2018

Dr Johan Henriksson. Image: MIMS

2019.06.25 | People

Introducing MIMS-EMBL Group Leaders: Johan Henriksson - T cell Systems Biology

Dr Johan Henriksson, who is originally from Sweden, joined MIMS in April 2019. His group mainly focuses on the quantitative analysis of gene regulatory networks. He works with advanced computer modelling to try and build an overall understanding into how genes are interconnected

Dr Jonas Barandun

2019.06.13 | People

Introducing MIMS-EMBL Group Leaders: Jonas Barandun - Structural Biology in infection medicine

Prior to joining MIMS as a group leader in spring 2019, Dr. Jonas Barandun was a postdoc in the group of Sebastian Klinge at the Rockefeller University, New York, USA. Dr. Barandun completed his PhD at the ETH Zurich in Switzerland, where he is also originally from

Barbara Sixt (second from left) with her research group at MIMS. Photo: MIMS

2019.05.29 | People

Introducing MIMS-EMBL group leaders: Barbara Sixt, Cell-autonomous immunity

Over the past 12 months, MIMS has recruited five new group leaders. Here, we meet Barbara Sixt, who joined MIMS as a Group Leader in May 2018. Dr. Sixt has already started to build up her group, with plans to further expand her team. The next year will see her focus on getting her research programme going.

Dr Björn Schröder. Photo: Christopher Coe
Fig 1. From: Schroeder BO, Gastroenterology Report 7(1), 2019, 3–12

2019.05.21 | Research news

Introducing MIMS-EMBL group leaders: Björn Ole Schröder - Gut microbiota and intestinal mucosal barrier function

Over the past 12 months, MIMS has recruited five new group leaders. In this interview series, we profile each new group leader and detail their research interests and hopes for their time at MIMS. Here, we introduce Björn O Schröder, who joined MIMS in April 2019.

The Nordic EMBL Partnership directors. (Left to right) Janna Saarela, Mark Daly, EMBL Director General Edith Heard, former EMBL Director General Iain Mattaj, Poul Nissen, Oliver Billker. Photo: Massimo del Prete/EMBL

2019.04.12 | People

Partners in the North

EMBL's 'Lab Matters' series profiles Nordic EMBL Partnership Directors

Dr. Emma Haapaniemi. Photo: Matti Immonen

2019.04.02 | Research news

Welcome to: Emma Haapaniemi, Group Leader, NCMM

Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.

Showing results 1 to 10 of 27

1 2 3 Next

Upcoming Partnership Events

Wed 25 Sep
14:30-14:30 | Barcelona, Spain
EMBL Partnership Conference
The 3rd annual EMBL Partnership conference will take place at EMBL Barcelona.
Thu 28 Nov
09:00-16:00 | EMBL Heidelberg
EMBL PhD Symposium
The symposium aims to promote interdisciplinary exchange among the next generation of life scientists.

News on publications

Dr. Jonas Barandun
Light microscopy image of microsporidian spores of Vairimorpha necatrix. Picture by Charles Vossbrinck
a) The cryo-EM density of the microsporidia ribosome solved by Jonas Barandun and his colleagues. The large ribosomal subunit is colored in shades of blue and green while the small ribosomal subunit is colored in shades of yellow and orange. Novel identified factors MDF1 and MDF2 are labeled. b) The microsporidia ribosomal RNA compared with yeast rRNA. The bar to the right compares the stretched RNA in length. c) A comparison of ribosomal structures of the microsporidium V. necatrix (to the right) with selected structures from major branches of the tree of life. Organism names are indicated below (P. falciparum: Malaria parasite, H. sapiens: human, S. cerevisiae: yeast, fungi). Ribosomal RNAs are depicted in light-blue (LSU, large subunit) and yellow (SSU, small subunit). Elements that are not present in microsporidia are colored in orange and dark-blue. Illustration by Jonas Barandun

2019.07.28 | Publication

Miniaturized version of ribosome found in microsporidia

A research team lead by MIMS/SciLifeLab research group leader Jonas Barandun uses cryo-electron microscopy to provide near atomic details of the smallest known eukaryotic cytoplasmic protein synthesis machine, the microsporidian ribosome.

2019.06.13 | Publication

DrugComb, a one-stop solution to all your cancer drug combination data analysis needs

Assistant Professor Jing Tang, a principal investigator of the Network Pharmacology group at FIMM and at the UH Faculty of Medicine has led the development of DrugComb, an open resource for harmonizing cancer drug combination studies. Dr. Tang hopes that DrugComb would become a collaborative data analysis platform that would bring forth more…

2019.03.15 | Publication

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.

The study was conducted by research groups lead by Jing Tang at the Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE) and the Faculty of Medicine and Caroline Heckman at FIMM. The results were recently published in PLOS Computational Biology.